Research Library
Methodology, trial data, and compound reference. Indexed to the primary literature. Free to read.
GLP-1 & Metabolic Peptides: A Research Overview
How the incretin system works, GLP-1, GIP, and glucagon signaling, and the progression from single to dual to triple receptor agonists in metabolic research.
GLP-1 & MetabolicSemaglutide vs Tirzepatide: Mechanism Comparison
Semaglutide activates one incretin receptor (GLP-1R); tirzepatide activates two (GIP+GLP-1R). Head-to-head trial evidence, mechanisms, and FDA status.
GLP-1 & MetabolicWhat Is Tirzepatide? The Science Explained
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP and GLP-1 receptor agonist. Science explainer: incretin mechanism, dual agonism, SURPASS and SURMOUNT trial evidence.
GLP-1 & MetabolicWhat Is Semaglutide? The Science Explained
Semaglutide is an FDA-approved GLP-1 receptor agonist (Ozempic, Wegovy). This educational overview explains the incretin mechanism, fatty-acid acylation, and the SUSTAIN and STEP clinical trial programs.
GLP-1 & MetabolicNAD+, NMN, and NR Research: What the Human Trials Actually Show
Mitochondrial & Longevity NAD+, NMN, and NR Research: What the Human Trials Actually Show Evidence-Tiered6 min readResearch use only Quick AnswerNAD+ is a coenzyme essential to…
GLP-1 & MetabolicTirzepatide Research: SURPASS, SURMOUNT, and the Trial Data
GLP-1 & Metabolic Tirzepatide Research: What the SURPASS and SURMOUNT Trials Showed Evidence-Tiered3 min readResearch use only Quick AnswerTirzepatide is a dual agonist that activates both…